Investment analysts at StockNews.com initiated coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Free Report) (TSE:AEZ) in a research note issued on Monday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock.
Aeterna Zentaris Trading Up 5.9 %
Shares of Aeterna Zentaris stock opened at $5.72 on Monday. The stock has a market capitalization of $10.26 million, a price-to-earnings ratio of -0.38 and a beta of 1.55. Aeterna Zentaris has a twelve month low of $3.96 and a twelve month high of $12.00. The business’s 50 day simple moving average is $4.77 and its 200-day simple moving average is $6.37.
About Aeterna Zentaris
Read More
- Five stocks we like better than Aeterna Zentaris
- CD Calculator: Certificate of Deposit Calculator
- 3 Key Stocks to Ride China’s Stimulus-Driven Growth
- What Are Dividend Achievers? An Introduction
- 3 Dividend Growth Stocks Set to Supercharge Your Portfolio
- 3 Stocks to Consider Buying in October
- 3 Small-Cap Stocks on the Way to Bigger and Better Days
Receive News & Ratings for Aeterna Zentaris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aeterna Zentaris and related companies with MarketBeat.com's FREE daily email newsletter.